DOI QR코드

DOI QR Code

Stability of Atenolol Tablet After Dispensing to Powder form at Community Pharmacies

근린약국에서 산제로 조제된 아테놀올정의 안정성

  • Published : 2004.08.20

Abstract

Prescription filling in powder form is performed in community pharmacy practice to adjust dose for children and patients who cannot swallow whole tablet. However, there are few reports regarding the stability of the active ingredient and possible microbial growth after the medication is dispensed to powder form. This study examined the stability of atenolol, an antihypertensive agent, and microbial growth in the unit dose pouches dispensed at twenty-one community pharmacies located in Taegu area. Randomly chosen first unit dose pouch contained 77.4% of the prescribed dose of the drug and there were only four community pharmacies that dispensed the drug within 10% deviation from the dose prescribed by physician. Surprisingly, there were three community pharmacies that dispensed the drug with greater than 40% deviation, which may pose a major concern regarding the efficacy and safety of the drug prescribed for the treatment of hypertension. Atenolol content during a month did not indicate significant change, showing 5.4%, 4.3%, and 3.3% of decrease in 50%, 80%, and 90% relative humidity conditions, respectively. Microbiological examination during a month showed less than 0.5 microorganism in high power field (hpf) in all the relative humidity conditions tested. Based on this study, pharmacy practice in community pharmacy needs to be rigorously regulated to ensure that the dose of the prescribed drug is properly incorporated into the unit dose pouch dispensed as powder form.

Keywords

References

  1. C.A Bond, C.L. Raehl and C. Claesson, International pharmacy, Phnnnacotherapy, 15, 586-591 (1995) https://doi.org/10.1002/j.1875-9114.1995.tb02867.x
  2. R.W. Holland and C.M. Nimmo, Transitions, part 1: beyond pharmaceutical care, Am. J. Health Syst. Phnrm., 56, 1758-1764 (1999)
  3. C.J. Hennansen-Kobulnicky, J.B. Wiederholt and B. Chewning, Adverse effect monitoring: opportunity for patient care and pharmacy practice, J. Am. Phnrm. Assoc, 44, 75-86 (2004) https://doi.org/10.1331/154434504322713264
  4. N.J. Facchinetti, G.M. Campbell and D.P. Jones, Evaluating dispensing error detection rates in a hospital pharmacy, Med. Care, 37, 39-43 (1999) https://doi.org/10.1097/00005650-199901000-00007
  5. D.B. Brushwood and K. Mullan, Corporate pharmacy's responsibility for a dispensing error, Am. J. Health Syst. Pharm., 53, 668-670 (1996)
  6. E. Zembrzuska-Sadkowska, Microbial contamination of pharmacies and hospital wards environment and its influence on the purity of prescription preparations during their production process as well as their application, Acta. Poz. Pharm., 52, 67-75 (1995)
  7. M.C. de la Rosa, M.R. Medina and e. Vivar, Microbiological quality of pharmaceutical raw materials, Phnrm. Acta. Helv., 70, 227-232 (1995) https://doi.org/10.1016/0031-6865(95)00022-2
  8. M. Windholz, S. Budavari, R. Blumetti and E. Otterbein(Eds), The Merck Index. 10th edition, Merck & Co Inc, New Jersey, U.S.A., MISC-103 (1983)
  9. H. Buunna, P.A de Smet, O.P. van den Hoff, H. Sysling, M. Storimans and A.C. Egberts, Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies, Pharm. World. Sci., 25, 280-287 (2003) https://doi.org/10.1023/B:PHAR.0000006521.41736.db